Canada Huntingtons Disease Treatment Market Size & Outlook
Canada huntingtons disease treatment market, 2018-2030 (US$M)
Related Markets
Canada huntingtons disease treatment market highlights
- The Canada huntingtons disease treatment market generated a revenue of USD 30.9 million in 2023 and is expected to reach USD 121.7 million by 2030.
- The Canada market is expected to grow at a CAGR of 21.7% from 2024 to 2030.
- In terms of segment, symptomatic treatment was the largest revenue generating treatment in 2023.
- Symptomatic Treatment is the most lucrative treatment segment registering the fastest growth during the forecast period.
Huntingtons disease treatment market data book summary
| Market revenue in 2023 | USD 30.9 million |
| Market revenue in 2030 | USD 121.7 million |
| Growth rate | 21.7% (CAGR from 2023 to 2030) |
| Largest segment | Symptomatic treatment |
| Fastest growing segment | Symptomatic Treatment |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Symptomatic Treatment |
Other key industry trends
- In terms of revenue, Canada accounted for 7.1% of the global huntingtons disease treatment market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. huntingtons disease treatment market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 121.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Huntingtons Disease Treatment Market Scope
Huntingtons Disease Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Canada huntingtons disease treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to huntingtons disease treatment market will help companies and investors design strategic landscapes.
Symptomatic treatment was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Canada huntingtons disease treatment market based on symptomatic treatment covering the revenue growth of each sub-segment from 2018 to 2030.
The Huntington’s disease treatment market is anticipated to witness growth owing to rising disease burden and availability of symptom management drugs in the market. According to Genetics Education Canada, the estimated prevalence of the disease is reported to be 13.7 per 100,000 of the population.
There is no curative therapy approved in the region; however, various clinical trials are being conducted to develop disease modifying therapies in Canada. Research grants provided by the government and nonprofit organizations such as Canadian Institutes of Health Research (CIHR) and Huntington Society of Canada are expected to help in improving treatment landscape.
For instance, in March 2021, University of Alberta received research grant of USD 1.04 million from CIHR for developing a curative therapy for HD. Currently, there are products such as Xenazine and Austedo for symptom management in Canada market.
Reasons to subscribe to Canada huntingtons disease treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada huntingtons disease treatment market databook
-
Our clientele includes a mix of huntingtons disease treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada huntingtons disease treatment market , including forecasts for subscribers. This country databook contains high-level insights into Canada huntingtons disease treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada huntingtons disease treatment market size, by treatment, 2018-2030 (US$M)
Canada Huntingtons Disease Treatment Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
